COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 16th, 2006 • Introgen Therapeutics Inc • Pharmaceutical preparations • New York
This Common Stock Purchase Agreement (the “Agreement”) is made as of the 4th day of November, 2005 by and between Introgen Therapeutics, Inc., a Delaware corporation (the “Company”), and Colgate-Palmolive Company, a Delaware corporation (the “Purchaser”).
ORAL HEALTHCARE ALLIANCE AGREEMENTOral Healthcare Alliance Agreement • March 16th, 2006 • Introgen Therapeutics Inc • Pharmaceutical preparations • New York
This ORAL HEALTHCARE ALLIANCE AGREEMENT (this “Agreement”), effective as of November 4th, 2005 (the “Effective Date”), is made by and between Introgen Therapeutics, Inc., a Delaware corporation, having a principal place of business at 301 Congress Ave, Suite 1850, Austin, Texas, 78701 (“Introgen”), and Colgate-Palmolive Company, a Delaware corporation, having a principal place of business at 300 Park Avenue, New York, New York, 10022 (“Colgate”). Introgen and Colgate are referred to herein as individually as a “Party” and collectively as the “Parties”.
